Table 1 Associations of APOE genotype with tau lesions of PSP
From: APOE ε2 is associated with increased tau pathology in primary tauopathy
Association with CBs | Association with NFTs | Association with TAs | Association with NTs | |||||
|---|---|---|---|---|---|---|---|---|
APOE genotype (comparisons made vs. the ε3/ε3 reference genotype) | Regression coefficient (95% CI) | P-value | Regression coefficient (95% CI) | P-value | Regression coefficient (95% CI) | P-value | Regression coefficient (95% CI) | P-value |
Presence of ε2 | 0.07 (0.00, 0.13) | 0.045 | 0.06 (0.00, 0.12) | 0.059 | 0.10 (0.03, 0.17) | 0.004 | 0.08 (0.01, 0.16) | 0.029 |
Presence of ε4 | 0.00 (−0.06, 0.07) | 0.88 | 0.00 (−0.06, 0.06) | 0.99 | 0.04 (−0.03, 0.10) | 0.23 | 0.01 (−0.06, 0.08) | 0.77 |
Presence of ε2/ε2 | −0.03 (−0.23, 0.16) | 0.74 | 0.10 (−0.08, 0.28) | 0.25 | −0.07 (−0.28, 0.13) | 0.48 | 0.01 (−0.21, 0.23) | 0.92 |
Presence of ε2/ε3 | 0.11 (0.03, 0.18) | 0.004 | 0.05 (−0.02, 0.12) | 0.15 | 0.12 (0.05, 0.20) | 0.002 | 0.11 (0.03, 0.19) | 0.010 |
Presence of ε2/ε4 | −0.07 (−0.23, 0.09) | 0.40 | 0.06 (−0.09, 0.21) | 0.41 | 0.11 (−0.06, 0.28) | 0.19 | −0.01 (−0.19, 0.17) | 0.92 |
Presence of ε3/ε4 | 0.02 (−0.05, 0.08) | 0.62 | 0.01 (−0.05, 0.07) | 0.86 | 0.04 (−0.03, 0.11) | 0.23 | 0.03 (−0.05, 0.10) | 0.47 |
Presence of ε4/ε4 | 0.03 (−0.17, 0.24) | 0.77 | −0.14 (−0.33, 0.05) | 0.15 | −0.07 (−0.28, 0.14) | 0.51 | −0.11 (−0.34, 0.12) | 0.35 |